Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine

  • Joanne M Langley1Email author,
  • Louise Frenette2,
  • Laurence Chu3,
  • Shelly McNeil1,
  • Scott Halperin1,
  • Ping Li4 and
  • David Vaughn4
BMC Infectious Diseases201212:279

DOI: 10.1186/1471-2334-12-279

Received: 16 December 2011

Accepted: 11 October 2012

Published: 30 October 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
16 Dec 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Jan 2012 Reviewed Reviewer Report - Jiehui Kevin Yin
24 Jan 2012 Reviewed Reviewer Report - Zol Vaj
30 Mar 2012 Author responded Author comments - Joanne Langley
Resubmission - Version 3
30 Mar 2012 Submitted Manuscript version 3
22 May 2012 Reviewed Reviewer Report - Jiehui Kevin Yin
4 Jun 2012 Reviewed Reviewer Report - Zol Vaj
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
21 Aug 2012 Author responded Author comments - Joanne Langley
Resubmission - Version 6
21 Aug 2012 Submitted Manuscript version 6
15 Sep 2012 Reviewed Reviewer Report - Zol Vaj
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
11 Oct 2012 Editorially accepted
30 Oct 2012 Article published 10.1186/1471-2334-12-279

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Canadian Center for Vaccinology, IWK Health Centre, Capital District Health Authority and Dalhousie University
(2)
Q&T Research Inc
(3)
Benchmark Research
(4)
GlaxoSmithKline Vaccines, King of Prussia

Advertisement